SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-007217
Filing Date
2018-07-02
Accepted
2018-07-02 08:31:35
Documents
8
Period of Report
2018-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 45126
2 CONVERTIBLE PROMISSORY NOTE ndra_ex41.htm EX-4.1 109771
3 FORM OF WARRANT ndra_ex42.htm EX-4.2 93566
4 SECURITIES PURCHASE AGREEMENT ndra_ex101.htm EX-10.1 215563
5 REGISTRATION RIGHTS AGREEMENT ndra_ex102.htm EX-10.2 85213
6 SECURITY AGREEMENT ndra_ex103.htm EX-10.3 152489
7 PRESS RELEASE ndra_ex991.htm EX-99.1 13506
8 IMAGE ndra_ex991000.jpg GRAPHIC 4332
  Complete submission text file 0001654954-18-007217.txt   722816
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 18931186
SIC: 3845 Electromedical & Electrotherapeutic Apparatus